Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Beam Therapeutics Inc Logo

ARKK Holdings of Beam Therapeutics (BEAM) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
November 24, 2021BUY1306000.0582%ARKK
November 19, 2021BUY957390.0436%ARKK
November 18, 2021BUY97600.0043%ARKK
November 17, 2021BUY1574640.0679%ARKK
November 16, 2021BUY36000.0016%ARKK

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$68.02
⚖️Weighting🧢Market Cap
2.52%$4.63b
🏋🏿‍♂️Weight Rank In ARKK🧮Price to Sales
175934.18
🏋️‍♀️Weight Rank Across All Funds🌏Country
17🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$85.248.73%
Description
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Website
beamtx.com

Research Notes and Commentary for BEAM